Dishman Pharma Inks MoU To Acquire Solvay’s Fine Chemicals Biz For Undisclosed Sum (Nasdaq) (RTTNews) - Monday, Dishman Pharmaceuticals & Chemicals announced that the company has inked a memorandum of understanding with Netherlands-based Solvay Pharmaceuticals BV, to acquire the fine chemicals, vitamin D and vitamin D analogues business from Solvay for an undisclosed sum. [News Source]